Company Information

  

Address: 5 SYLVAN WAY
SUITE 300 
City: PARSIPPANY 
State: NJ 
Zip Code: 07054 
Telephone: 973-254-3560 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

Pacira Pharmaceuticals, Inc., a Delaware corporation, is the holding company for our California operating subsidiary of the same name, or Pacira California. In March 2007, we acquired Pacira California from SkyePharma Holdings, Inc., or Skyepharma (referred to in this Annual Report on Form 10-K as the "Acquisition"). Unless the context requires otherwise, references to "Pacira," "we," the "Company," "us" and "our" in this Annual Report on Form 10-K refers to Pacira Pharmaceuticals, Inc., a Delaware corporation, and its subsidiaries. Corporate Information We were incorporated in Delaware under the name Blue Acquisition Corp. in December 2006 and changed our name to Pacira, Inc. in June 2007. In October 2010, we changed our name to Pacira Pharmaceuticals, Inc. Our principal executive offices are located in Parsippany, New Jersey.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
06/2017-1.71NAN/E
03/2017-1.44NAN/E
12/2016-1.02NAN/E
09/2016-0.07NAN/E
06/20160.73NA46.21
03/20160.95NA55.77
12/20150.95NA80.83
09/20150.28NA146.79

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity-0.07Total Liab/Total Assets0.44
Net Inc/Total Assets-0.10Total Liab/Inv Cap0.50
Net Inc/Inv Cap-0.11Total Liab/Comm Equity0.31
Pretax Inc/Net Sales-0.14Interest Coverage Ratio-4.36
Net Inc/Net Sales-0.14Curr Debt/EquityNA
Cash Flow/Net Sales0.12LTD/Equity0.50
SG&A/NetSales0.55Total Debt/Equity0.50
Asset Utilization   Liquidity  
Net Receivables Turnover9.91Quick Ratio4.72
Inventory Turnover2.37Current Ratio5.42
Inventory Day Sales0.01Net Rec/Curr Assets0.12
Net Sales/Work Cap1.39Inv/Curr Assets0.13
Net Sales/PP&E2.74  

Income Statement (Millions)

  6/30/2017 3/31/2017 12/31/2016 9/30/2016
Total Revenues(Net Sales) 70.93 69.28 72.90 68.36
Cost of Goods Sold 23.81 24.58 23.62 43.15
Selling & Admin Exps 44.05 42.12 34.67 36.31
Operating Income -15.78 -14.05 -2.46 -20.87
Interest Exp 5.23 2.59 1.86 1.60
Pretax Income -19.71 -19.84 -3.99 -22.13
Other Income 1.29 -3.20 0.33 0.34
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -19.74 -19.87 -3.97 -22.17

Balance Sheet (Millions)

Assets 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Cash & Short Term Investments 382.44 383.70 172.60 161.13
Receivables - Total 27.47 27.70 29.94 26.77
Inventories - Total 33.60 30.31 31.28 37.48
Total Current Assets 450.99 447.96 243.09 235.44
Net Property, Plant & Equipment 103.24 102.57 101.02 100.39
Total Assets 605.75 599.96 391.47 381.15
Liabilities        
Accounts Payable 57.19 44.37 44.24 38.45
Debt in Current Liabilities 0.32 0.76 0.00 107.56
Total Current Liabilities 57.51 45.65 44.84 146.83
Long-Term Debt 269.33 265.99 108.74 NA
Total Liabilities 344.70 329.33 172.49 167.01
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 0.04 0.04 0.04 0.04
Retained Earnings -386.13 -366.39 -346.24 -342.27
Treasury Stock NA NA NA NA
Total Stockholders' Equity 261.05 270.63 218.98 214.15
Total Liabilities and Stockholders' Equity 605.75 599.96 391.47 381.15

Cash Flow Summary (Millions)

Categories 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Net Cash Provided by Operating Activities 3.66 0.01 17.35 11.68
Net Cash Provided by Investing Activities -61.15 -143.84 -6.92 -13.32
Net Cash Provided by Financing Activities 2.34 216.86 1.07 0.77

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/201239.08-52.28-1.72
12/201385.55-63.91-1.93
12/2014197.67-13.72-0.39
12/2015249.001.860.95
12/2016276.37-37.95-1.02
Growth Rates63.07----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/1722541,244--




Report Date : 10/16/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.